In this study, the direct inhibition of CCL4 with specific antibodies decreased vascular inflammation, reduced the plaque area, and stabilized the vulnerability of atheroma in a mouse model of atherosclerosis in vivo. The gene discussed is CCL4; the disease is atherosclerosis.